CRISPR-Cas9 sgRNA Library

CRISPR-Cas9 sgRNA Library

CRISPR-Cas9/gRNA (CRISPR-Cas RNA-Guided nuclease) is considered as the biggest breakthrough in genome editing technology after TALEN and ZFN. It precisely edits DNA through the RNA-directed Cas9 nuclease. Previous studies indicated that the on-target gene knockout rates were higher than that of TALEN and ZFN. Besides, the construction of sgRNA-Cas9 is easier and more convenient. It has been widely applied to animal and plant breeding, directed evolution, and the site-specific restoration of genetic diseases. Synbio Technologies offers the designing, construction and validation of CRISPR-Cas9 gene targeting system through our patent pending synthetic biology platform in a highly cost and time-effective approach. We offer one station solutions for CRISPR Cas9 projects, including genome scale gene targeting.

Synbio Technologies is building up the first integrated GPS (Genotype, Phenotype and Synotype) system aimed to a quick and easy translation or reverse translation between "Genotype" and "Phenotype" by using our proprietary "Synotype" platform. The company's scientific capabilities encompass areas such as DNA engineering, DNA synthesis, genome synthesis, pathway synthesis, synthetic biology, pharmacogenomics, microbiology, translational biology and the applications of synthetic biology. Synbio Technologies' team has a proven track record regarding translating scientific breakthroughs into cost effective biological solution.